NOT FOR DISTRIBUTION
Header cover image

IHH Healthcare Berhad

Market Cap

RM49.3b

Last Updated

2021/05/07 11:05 UTC

Data Sources

Company Financials +

Executive Summary

IHH Healthcare Berhad, an investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, and internationally. More Details


Snowflake Analysis

Adequate balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IHH is less volatile than 75% of MY stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: IHH's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

5.2%

IHH

2.9%

MY Healthcare

-1.8%

MY Market


1 Year Return

9.7%

IHH

9.9%

MY Healthcare

20.9%

MY Market

Return vs Industry: IHH matched the MY Healthcare industry which returned 9.9% over the past year.

Return vs Market: IHH underperformed the MY Market which returned 20.9% over the past year.


Shareholder returns

IHHIndustryMarket
7 Day5.2%2.9%-1.8%
30 Day4.8%4.2%-0.9%
90 Day11.6%8.7%1.0%
1 Year10.5%9.7%10.7%9.9%24.6%20.9%
3 Year-4.1%-6.4%-3.1%-5.9%0.5%-8.9%
5 Year-11.2%-14.2%-9.6%-13.3%15.0%-4.5%

Long-Term Price Volatility Vs. Market

How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is IHH Healthcare Berhad undervalued compared to its fair value and its price relative to the market?

249.56x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: IHH (MYR5.66) is trading above our estimate of fair value (MYR5.61)

Significantly Below Fair Value: IHH is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IHH is poor value based on its PE Ratio (249.6x) compared to the MY Healthcare industry average (60.9x).

PE vs Market: IHH is poor value based on its PE Ratio (249.6x) compared to the MY market (20.6x).


Price to Earnings Growth Ratio

PEG Ratio: IHH is poor value based on its PEG Ratio (6.2x)


Price to Book Ratio

PB vs Industry: IHH is good value based on its PB Ratio (2.1x) compared to the MY Healthcare industry average (2.6x).


Future Growth

How is IHH Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

40.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IHH's forecast earnings growth (40.3% per year) is above the savings rate (3.6%).

Earnings vs Market: IHH's earnings (40.3% per year) are forecast to grow faster than the MY market (15.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IHH's revenue (9.9% per year) is forecast to grow faster than the MY market (7.2% per year).

High Growth Revenue: IHH's revenue (9.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IHH's Return on Equity is forecast to be low in 3 years time (6.2%).


Past Performance

How has IHH Healthcare Berhad performed over the past 5 years?

-32.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IHH has a large one-off loss of MYR170.4M impacting its December 31 2020 financial results.

Growing Profit Margin: IHH's current net profit margins (1.5%) are lower than last year (3.1%).


Past Earnings Growth Analysis

Earnings Trend: IHH's earnings have declined by 32.9% per year over the past 5 years.

Accelerating Growth: IHH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: IHH had negative earnings growth (-56.6%) over the past year, making it difficult to compare to the Healthcare industry average (-36.2%).


Return on Equity

High ROE: IHH's Return on Equity (0.8%) is considered low.


Financial Health

How is IHH Healthcare Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: IHH's short term assets (MYR7.3B) exceed its short term liabilities (MYR5.6B).

Long Term Liabilities: IHH's short term assets (MYR7.3B) do not cover its long term liabilities (MYR11.9B).


Debt to Equity History and Analysis

Debt Level: IHH's debt to equity ratio (35.8%) is considered satisfactory.

Reducing Debt: IHH's debt to equity ratio has increased from 29.4% to 35.8% over the past 5 years.

Debt Coverage: IHH's debt is well covered by operating cash flow (25.2%).

Interest Coverage: IHH's interest payments on its debt are well covered by EBIT (3.9x coverage).


Balance Sheet


Dividend

What is IHH Healthcare Berhad current dividend yield, its reliability and sustainability?

0.71%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: IHH's dividend (0.71%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (1.33%).

High Dividend: IHH's dividend (0.71%) is low compared to the top 25% of dividend payers in the MY market (3.92%).


Stability and Growth of Payments

Stable Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.

Growing Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: IHH is not paying a notable dividend for the MY market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IHH's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Kelvin Loh (46 yo)

1.33yrs

Tenure

RM9,936,000

Compensation

Dr. Chi-Keon Loh, also known as Kelvin, serves as Managing Director and Chief Executive Officer of IHH Healthcare Berhad since January 1, 2020 and serves as its Executive Director since July 01, 2019. He h...


CEO Compensation Analysis

Compensation vs Market: Kelvin's total compensation ($USD2.41M) is above average for companies of similar size in the MY market ($USD1.05M).

Compensation vs Earnings: Insufficient data to compare Kelvin's compensation with company performance.


Leadership Team

Experienced Management: IHH's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: IHH's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IHH Healthcare Berhad
  • Ticker: IHH
  • Exchange: KLSE
  • Founded: 1974
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: RM49.251b
  • Shares outstanding: 8.78b
  • Website: https://www.ihhhealthcare.com

Number of Employees


Location

  • IHH Healthcare Berhad
  • Pantai Hospital Kuala Lumpur
  • Level 11, Block A
  • Kuala Lumpur
  • Wilayah Persekutuan
  • 59100
  • Malaysia

Listings


Biography

IHH Healthcare Berhad, an investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, and internationally. It provides primary care services, such as treatment of basic ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/07 11:05
End of Day Share Price2021/05/07 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.